Protea, Gelcompany to Collaborate on Protein Analysis Products | GenomeWeb

NEW YORK (GenomeWeb News) – Protea Biosciences and Gelcompany, a wholly owned subsidiary of Australian firm Fluorotechnics, today said that they will collaborate on developing new technology for improved protein analysis.

Under the agreement, Protea has the right to distribute certain Gelcompany products in the North American life sciences market. The companies also said that they intend to collaborate on the co-development of new protein separation products for the global life sciences market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.